.
MergerLinks Header Logo

Announced

Completed

Ally Bridge Group led a $120m funding round in Rapid Micro Biosystems.

Financials

Edit Data
Transaction Value£97m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Friendly

Biotechnology

Private

United States

Minority

Private Equity

Single Bidder

microbial detection technology

Acquisition

Completed

Venture Capital

Synopsis

Edit

Ally Bridge Group led a $120m funding round in Rapid Micro Biosystems, a provider of automated microbial detection technology for biopharmaceutical manufacturing. "We expect to see strong adoption of the company’s products, as increasing numbers of biopharmaceutical companies seek to take advantage of leading-edge technologies to support manufacturing speed and capacity improvements, as well as ensuring quality to satisfy increasingly stringent regulatory requirements," Frank Yu, Ally Bridge Group Founder, CEO and CIO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US